Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

PT429 – From Mycophobia to Fungi Fever: The Psychedelic Space’s Growing...

Natural Medicine Advisory Bulletin #2: July 2023

COMPASS Pathways Announces Second Quarter 2023 Financial Results and Business Highlights

Across the Threshold: A Fireside on NDE’s with Psychedelics Today

Psyence Group Announces SEC Registration Filing with NASDAQ SPAC, Newcourt, and Signing...

Navigating Psychedelics For Clinicians and Wellness Practitioners: Australia

Navigating Psychedelics: Vital Tools for Risk Reduction and Integration – Miami

Reunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of...

PT428 – The Promise of MAPS’ Phase III Data, Psychedelics and...

1...525354...218 Page 53 of 218

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin